|
FDA: Despite Early Warning Signs NECC Failed to Fix Problems
The New England Compounding Center (NECC), at the heart of a nationwide fungal meningitis outbreak, dropped the ball after seeing early signs of unacceptable levels of microbial contamination, the FDA says.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives